M

Macrogen Inc
KOSDAQ:038290

Watchlist Manager
Macrogen Inc
KOSDAQ:038290
Watchlist
Price: 15 840 KRW -0.19%
Market Cap: 171.7B KRW

Operating Margin

-3.6%
Current
Declining
by 0.9%
vs 3-y average of -2.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.6%
=
Operating Income
₩-6.5B
/
Revenue
₩180B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.6%
=
Operating Income
₩-6.5B
/
Revenue
₩180B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Macrogen Inc
KOSDAQ:038290
172.1B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
240.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
171B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
278.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 73% of companies in Korea
Percentile
27th
Based on 2 615 companies
27th percentile
-3.6%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Macrogen Inc
Glance View

Macrogen, Inc. engages in the provision genetic research and biotechnology services. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-02-22. The firm operates its business through four divisions: deoxyribonucleic acid (DNA) sequencing division, DNA chips division, transgenic and knockout mouse division and oligonucleotide DNA division. Its DNA sequencing division provides genome sequencing analysis services. Its DNA chips division develops DNA chips products, such as Illumina chips, MacArray chips and customized chips. Its transgenic and knockout mouse division offers gene engineering services. Its oligonucleotide DNA division offers oligonucleotide DNA manufacturing services. The firm operates its business within domestic market and in overseas markets.

Macrogen Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-3.6%
=
Operating Income
₩-6.5B
/
Revenue
₩180B
What is Macrogen Inc's current Operating Margin?

The current Operating Margin for Macrogen Inc is -3.6%, which is below its 3-year median of -2.7%.

How has Operating Margin changed over time?

Over the last 3 years, Macrogen Inc’s Operating Margin has decreased from 3.2% to -3.6%. During this period, it reached a low of -5.4% on Mar 31, 2025 and a high of 3.8% on Dec 31, 2022.

Back to Top